Intuitive Surgical Expands Direct Robotic Operations in Southern Europe

The latest announcement is out from Intuitive Surgical ( (ISRG) ).

On March 1, 2026, Intuitive completed its acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates, as announced on March 2. The deal shifts distribution in Italy, Spain, Portugal, Malta, San Marino, and associated territories to a direct model, integrating these activities into Intuitive’s European commercial and marketing organization under Senior Vice President and General Manager Dirk Barten.

The acquisition expands Intuitive’s operational footprint in Southern Europe, where there were more than 470 installed da Vinci systems in Italy, Spain, and Portugal as of December 31, 2025, and where the Ion system was recently launched in Italy and Spain. Intuitive is also adding about 250 employees from the acquired businesses, a move expected to improve customer support, strengthen its competitive position in European robotic surgery, and potentially accelerate adoption of minimally invasive care across the region.

The most recent analyst rating on (ISRG) stock is a Hold with a $570.00 price target. To see the full list of analyst forecasts on Intuitive Surgical stock, see the ISRG Stock Forecast page.

Spark’s Take on ISRG Stock

According to Spark, TipRanks’ AI Analyst, ISRG is a Outperform.

ISRG scores well primarily on strong financial performance (high margins, robust cash generation, very low leverage) and a largely positive earnings outlook with solid procedure growth guidance and increasing recurring revenue mix. The score is held back by bearish technical signals (price below key moving averages with negative MACD) and a demanding valuation (P/E 62.57), alongside guided near-term margin pressure from tariffs and mix.

To see Spark’s full report on ISRG stock, click here.

More about Intuitive Surgical

Intuitive Surgical, headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and a pioneer of robotic-assisted surgery, best known for its da Vinci surgical system and Ion endoluminal system. The company focuses on uniting advanced systems, learning programs, and value-enhancing services to help physicians deliver less invasive, more efficient care across multiple surgical specialties worldwide.

Average Trading Volume: 1,884,357

Technical Sentiment Signal: Hold

Current Market Cap: $178.8B

See more data about ISRG stock on TipRanks’ Stock Analysis page.